# Case Report: Twists and turns: a case of cervical mesonephric adenocarcinoma on contrast-enhanced ultrasound

**Authors:** Qiuyun Huang, Yunhao Luo, Jia Xu, Kewen Ding, Fangqin Liu, Lang Qiao

PMC · DOI: 10.3389/fonc.2026.1726429 · Frontiers in Oncology · 2026-02-06

## TL;DR

This case report describes a rare cervical cancer diagnosed using contrast-enhanced ultrasound, which helped improve diagnostic accuracy.

## Contribution

The study highlights the diagnostic value of contrast-enhanced ultrasound in identifying rare cervical mesonephric adenocarcinoma.

## Key findings

- MRI initially suggested inflammatory lesions, but CEUS indicated malignancy.
- CEUS provides detailed perfusion information, aiding in accurate diagnosis.
- Surgical pathology confirmed the diagnosis of cervical mesonephric adenocarcinoma.

## Abstract

Cervical mesonephric adenocarcinoma is an extremely rare malignant tumor that originates from the mesonephric duct remnants on the lateral wall of the cervix and is a unique subtype of cervical epithelial tumors. Due to its rarity and non-specific clinical manifestations, early diagnosis is challenging. We report a case of 61-year-old female patient who presented with vaginal bleeding lasting over one month. Following conventional transvaginal ultrasound, contrast-enhanced ultrasound (CEUS), and magnetic resonance imaging (MRI) examination, MRI preliminary diagnosis suggested inflammatory lesions, while CEUS indicated malignant tumors. Finally, the patient underwent surgical treatment, and the pathological diagnosis was mesonephric adenocarcinoma of the cervix. Previous studies have shown that cervical mesonephric adenocarcinoma, often appears atypical on two-dimensional and color Doppler ultrasound. CEUS offers significant advantages in displaying the microvascular architecture of tumors and can provide more detailed and abundant perfusion information, thereby helping to improve the accuracy of diagnosis.

## Linked entities

- **Diseases:** cervical mesonephric adenocarcinoma (MONDO:0003410)

## Full-text entities

- **Genes:** EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}, GATA3 (GATA binding protein 3) [NCBI Gene 2625] {aka HDR, HDRS}, KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}, WT1 (WT1 transcription factor) [NCBI Gene 7490] {aka AWT1, GUD, NPHS4, WAGR, WIT-2, WT-1}, PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}, CDKN2A (cyclin dependent kinase inhibitor 2A) [NCBI Gene 1029] {aka ARF, CAI2, CDK4I, CDKN2, CMM2, INK4}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, PAX8 (paired box 8) [NCBI Gene 7849] {aka PAX-8}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, MME (membrane metalloendopeptidase) [NCBI Gene 4311] {aka CALLA, CD10, CMT2T, NEP, SCA43, SFE}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, MUC1 (mucin 1, cell surface associated) [NCBI Gene 4582] {aka ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3}, TTF1 (transcription termination factor 1) [NCBI Gene 7270] {aka TTF-1, TTF-I}
- **Diseases:** inflammatory (MESH:D007249), abscess (MESH:D000038), cervical cancer (MESH:D002583), vaginal tumor (MESH:D014625), malignancy (MESH:D009369), Cervical mesonephric adenocarcinoma (MESH:D000230), cervical epithelial tumor (MESH:D002277), bleeding (MESH:D006470), fatigue (MESH:D005221), hypoalbuminemia (MESH:D034141), neoplastic lesion (MESH:D009062), HPV infection (MESH:D030361), masses (MESH:C536030), anemia (MESH:D000740), Tumor thrombus (MESH:D013927), distant metastasis (MESH:D009362), serous, clear-cell, or endometrioid adenocarcinomas (MESH:D018262), vaginal bleeding (MESH:D014592), cervical/endometrial adenocarcinomas (MESH:D016889), ulcerative (MESH:D014456), dizziness (MESH:D004244), cervical leiomyoma (MESH:D007889), mesonephric hyperplasia (MESH:D006965), necrotic (MESH:D009336)
- **Chemicals:** Paraffin (MESH:D010232), HE (MESH:D006371), hematoxylin (MESH:D006416), eosin (MESH:D004801)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12920179/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12920179/full.md

## References

17 references — full list in the complete paper: https://tomesphere.com/paper/PMC12920179/full.md

---
Source: https://tomesphere.com/paper/PMC12920179